HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
VICTORIA Study Group Selected Research
VICTORIA Study Group Research Topics
Disease
25
Heart Failure
03/2024 - 12/2019
4
Myocardial Infarction
01/2022 - 12/2019
3
Hypotension (Low Blood Pressure)
01/2022 - 01/2020
2
Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 12/2019
2
Atrial Fibrillation
01/2021 - 12/2019
1
Glycogen Storage Disease Type II (Pompe's Disease)
01/2023
1
Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2023
1
Inflammation (Inflammations)
01/2023
1
Cardiomyopathies (Cardiomyopathy)
01/2022
1
Syncope (Fainting)
01/2020
1
Hypertension (High Blood Pressure)
12/2019
1
Stroke (Strokes)
12/2019
Drug/Important Bio-Agent (IBA)
25
vericiguat
IBA
03/2024 - 12/2019
4
Brain Natriuretic Peptide (Natrecor)
FDA Link
10/2023 - 05/2021
2
Diuretics
IBA
03/2024 - 01/2020
2
pro-brain natriuretic peptide (1-76)
IBA
10/2023 - 01/2022
2
Soluble Guanylyl Cyclase
IBA
01/2023 - 01/2020
2
Bilirubin
IBA
06/2021 - 05/2021
2
Hormones (Hormone)
IBA
06/2021 - 05/2021
2
Albumins
IBA
06/2021 - 05/2021
2
Uric Acid (Urate)
IBA
06/2021 - 05/2021
2
Chlorides
IBA
06/2021 - 05/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
Interleukin-6 (Interleukin 6)
IBA
01/2023
1
Transaminases (Aminotransferases)
IBA
01/2023
1
sacubitril and valsartan sodium hydrate drug combination
IBA
01/2022
1
Angiotensin Receptors (Angiotensin II Receptor)
IBA
11/2021
1
Neprilysin (Neutral Endopeptidase)
IBA
11/2021
1
Rivaroxaban
IBA
12/2019
Therapy/Procedure
2
Therapeutics
01/2023 - 01/2020
1
Percutaneous Coronary Intervention
01/2022
1
Coronary Artery Bypass (Coronary Artery Bypass Surgery)
01/2022
1
Patient Readmission
12/2019